URO ONCO

Welcome, this website is intended for all international healthcare professionals in uro-oncology. By clicking the link below you are declaring and confirming that you are a healthcare professional.

This Resource Centre will retire this year and will not be available after 31 December 2017. Content will remain here for browsing and downloading prior to that date. Thank you for your interest.

URO ONCO


The European Association of Urology and Elsevier are proud to present URO ONCO, the online educational platform for all healthcare professionals in uro-oncology.

URO ONCO provides up-to-date information on developments in the field of urological malignancies. With urological tumours presenting three of the ten most commonly found cancers, the need for up-to-date cancer management knowledge is essential for urologists

ASCO 2017 highlights and editor recommendations

  • Selected meeting abstracts - including editorial comment
  • Expert interviews on a range of Uro-oncology topics including
  • News reports from the ASCO Annual meeting
  • Related ASCO 2017 resources

This Resource Centre will retire this year and will not be available after 31 December 2017.
Content will remain here for browsing and downloading prior to that date. Thank you for your interest.

(closes after 5 sec.)

Expert interviews on clinical trial results and breaking news in uro-oncology from ASCO Annual meeting

Latest Headlines in Prostate


Latest Headlines in Bladder


Latest Headlines in Kidney

  • Bosniak Classification for Complex Renal Cysts Reevaluated: A Systematic Review

    Schoots IG, Zaccai K, Hunink MG, Verhagen PCMS.

    J Urol. 2017 Jul;198(1):12-21.
    Category:
    Tag:

    Editorial comment from Piotr Chlosta:
    In a systematic review evaluating Bosniak classification system for complex renal cysts, the authors conclude that its effectiveness was high for categories II, IIF and IV, whereas low for category III. In category III, surgical overtreatment rate was 49% because of benign pathology. This, together with good oncological outcomes of Bosniak III cysts might suggest that surveillance could be an alternative approach for consideration in this group, warranting further studies to assess safety of surveillance strategy.

  • Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis

    European Urology, Volume 71, Issue 1, January 2017, Pages 111 - 117

    Category:
    Tag:

    Editorial comment from Piotr Chlosta: Patients treated with cryoablation(CA) for cT1b renal tumors had a significantly higher rate of local cancer recurrence at 1 year compared to those treated with partial nephrectomy (PN). The authors found a higher but not significantly different postoperative complication rate for the PN group, a significantly higher local recurrence rate for the CA group, and similar overall and cancer-specific survival. The role of CA for cT1b RCC need to be determined.


Editor’s Introduction to URO ONCO

Introduction to URO ONCO Resource Centre from the Editor, Prof. Piotr Chlosta

E-Alert

Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

Subscribe

URO ONCO is made possible by an unrestricted educational grant from:

The editorial independence of the resource centre is mandatory and recognized by the EAU and Elsevier.

The journal articles, videos and statements published on the resource centre have been selected independently and without influence from Elsevier, European Urology Editors or the sponsor and do not necessarily reflect their opinions or views.

Expert interviews on clinical trial results and breaking news in uro-oncology from ASCO Annual meeting

EAU 2017 Scientific Programme and Sessions

View the Scientific Programme and Sessions of the 2017 EAU Annual Congress, Munich, Germany.

Congress Planner

EAU Guidelines


URO ONCO is made possible by an unrestricted educational grant from:

  Janssen Pharmaceutical Companies